{"id":"https://openalex.org/W2164090695","doi":"https://doi.org/10.4172/jbb.1000050","title":"Development and Characterization of Solid-Lipid Microparticles of Highly Insoluble Drug Sirolimus","display_name":"Development and Characterization of Solid-Lipid Microparticles of Highly Insoluble Drug Sirolimus","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2164090695","doi":"https://doi.org/10.4172/jbb.1000050","mag":"2164090695"},"language":"en","primary_location":{"id":"doi:10.4172/jbb.1000050","doi":"https://doi.org/10.4172/jbb.1000050","is_oa":true,"landing_page_url":"https://doi.org/10.4172/jbb.1000050","pdf_url":"https://www.omicsonline.org/development-and-characterization-of-solid-lipid-microparticles-of-highly-insoluble-drug-sirolimus-jbb.1000050.pdf","source":{"id":"https://openalex.org/S102451085","display_name":"Journal of Bioequivalence & Bioavailability","issn_l":"0975-0851","issn":["0975-0851"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bioequivalence & Bioavailability","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.omicsonline.org/development-and-characterization-of-solid-lipid-microparticles-of-highly-insoluble-drug-sirolimus-jbb.1000050.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111801342","display_name":"Basavaraj K. Nanjwade","orcid":"https://orcid.org/0000-0001-7724-4415","observed_orcids":["https://orcid.org/0000-0001-7724-4415"]},"institutions":[{"id":"https://openalex.org/I4210125823","display_name":"KLE Academy of Higher Education and Research","ror":"https://ror.org/03aam9155","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210125823"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Basavaraj K. Nanjwade","raw_affiliation_strings":["Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","institution_ids":["https://openalex.org/I4210125823"]},{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","institution_ids":["https://openalex.org/I4210125823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038118604","display_name":"Didhija J. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125823","display_name":"KLE Academy of Higher Education and Research","ror":"https://ror.org/03aam9155","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210125823"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Didhija J. Patel","raw_affiliation_strings":["Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","institution_ids":["https://openalex.org/I4210125823"]},{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","institution_ids":["https://openalex.org/I4210125823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009866730","display_name":"Kemy A. Parikh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125823","display_name":"KLE Academy of Higher Education and Research","ror":"https://ror.org/03aam9155","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210125823"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kemy A. Parikh","raw_affiliation_strings":["Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","institution_ids":["https://openalex.org/I4210125823"]},{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","institution_ids":["https://openalex.org/I4210125823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074558681","display_name":"Veerendra K. Nanjwade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125823","display_name":"KLE Academy of Higher Education and Research","ror":"https://ror.org/03aam9155","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210125823"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Veerendra K. Nanjwade","raw_affiliation_strings":["Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","institution_ids":["https://openalex.org/I4210125823"]},{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","institution_ids":["https://openalex.org/I4210125823"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022639235","display_name":"F. V. Manvi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125823","display_name":"KLE Academy of Higher Education and Research","ror":"https://ror.org/03aam9155","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210125823"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"F. V. Manvi","raw_affiliation_strings":["Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, Belgaum, India","institution_ids":["https://openalex.org/I4210125823"]},{"raw_affiliation_string":"Department of Pharmaceutics, KLE University College of Pharmacy, BELGAUM, INDIA -590010,","institution_ids":["https://openalex.org/I4210125823"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111801342"],"corresponding_institution_ids":["https://openalex.org/I4210125823"],"apc_list":null,"apc_paid":null,"fwci":1.4861,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.76629712,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"03","issue":"01","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4115999937057495,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solid-lipid-microparticles","display_name":"solid lipid microparticles","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":1.0},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.8889999985694885},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hot-homogenization","display_name":"hot homogenization","score":0.8659999966621399},{"id":"https://openalex.org/keywords/glycerol-monostearate","display_name":"glyceryl monostearate","score":0.996999979019165},{"id":"https://openalex.org/keywords/sodium-taurocholate","display_name":"sodium taurocholate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.9570000171661377},{"id":"https://openalex.org/keywords/in-vitro-drug-release","display_name":"in vitro drug release","score":0.8560000061988831},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.7369999885559082},{"id":"https://openalex.org/keywords/stability-testing","display_name":"stability testing","score":0.5799999833106995},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.7742822170257568},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6434470415115356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5142378211021423},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.4782634973526001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40746602416038513},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.37642771005630493},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3740544319152832},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1616155505180359}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4172/jbb.1000050","doi":"https://doi.org/10.4172/jbb.1000050","is_oa":true,"landing_page_url":"https://doi.org/10.4172/jbb.1000050","pdf_url":"https://www.omicsonline.org/development-and-characterization-of-solid-lipid-microparticles-of-highly-insoluble-drug-sirolimus-jbb.1000050.pdf","source":{"id":"https://openalex.org/S102451085","display_name":"Journal of Bioequivalence & Bioavailability","issn_l":"0975-0851","issn":["0975-0851"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bioequivalence & Bioavailability","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4172/jbb.1000050","doi":"https://doi.org/10.4172/jbb.1000050","is_oa":true,"landing_page_url":"https://doi.org/10.4172/jbb.1000050","pdf_url":"https://www.omicsonline.org/development-and-characterization-of-solid-lipid-microparticles-of-highly-insoluble-drug-sirolimus-jbb.1000050.pdf","source":{"id":"https://openalex.org/S102451085","display_name":"Journal of Bioequivalence & Bioavailability","issn_l":"0975-0851","issn":["0975-0851"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bioequivalence & Bioavailability","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2164090695.pdf","grobid_xml":"https://content.openalex.org/works/W2164090695.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W255240257","https://openalex.org/W1964026121","https://openalex.org/W1973685311","https://openalex.org/W1981468523","https://openalex.org/W2011920500","https://openalex.org/W2012272386","https://openalex.org/W2019649784","https://openalex.org/W2022850278","https://openalex.org/W2024257431","https://openalex.org/W2029476055","https://openalex.org/W2035029345","https://openalex.org/W2044985759","https://openalex.org/W2050903914","https://openalex.org/W2172159375","https://openalex.org/W2287646976"],"related_works":["https://openalex.org/W2081834609","https://openalex.org/W2024634456","https://openalex.org/W2047339084","https://openalex.org/W2390450633","https://openalex.org/W1979435563","https://openalex.org/W2315400498","https://openalex.org/W2795599795","https://openalex.org/W2312243875","https://openalex.org/W2777824951","https://openalex.org/W2415912553"],"abstract_inverted_index":{"Solid":[0],"lipid":[1,33,67],"microparticles":[2,34,68],"(SLMs)":[3],"represent":[4],"an":[5,41],"alternative":[6],"carrier":[7,12],"system":[8],"to":[9,28,45,50,115,127,143,169],"traditional":[10],"colloidal":[11],"such":[13],"as":[14],"emulsion,":[15],"liposomes":[16],"and":[17,20,30,49,81,100,108,153],"polymeric":[18],"micro":[19],"nanoparticles.The":[21],"purpose":[22],"of":[23,35,78,119,162],"this":[24],"research":[25],"work":[26],"was":[27,113,125,134,141],"develop":[29],"evaluate":[31],"solid":[32,66],"sirolimus":[36],"for":[37,87,102,159],"oral":[38,160],"delivery.Sirolimus":[39],"is":[40,55,63],"immunosupressive":[42],"drug":[43,92],"used":[44,158],"prevent":[46],"transplant":[47],"rejection":[48],"treat":[51],"auto":[52],"immune":[53],"diseases.It":[54],"a":[56],"macrolide":[57],"lactone":[58],"produced":[59],"by":[60,71,122],"streptomyces":[61],"hydroscopicus.It":[62],"extremely":[64],"hydrophobic.Sirolimus":[65],"were":[69,85],"prepared":[70],"hot":[72],"homogenization":[73],"technique.The":[74],"matrix":[75],"chiefly":[76],"consisted":[77],"glyceryl":[79,151],"monostearate":[80,152],"sodium":[82,154],"taurocholate.The":[83],"SLMs":[84,120],"studied":[86],"its":[88],"particle":[89,111],"size":[90,112],"analysis,":[91],"content,":[93],"entrapment":[94,131],"efficiency,":[95],"in":[96,146],"vitro":[97],"release":[98,136],"characteristics":[99],"also":[101],"stability":[103],"analysis":[104,124],"at":[105],"different":[106],"temperature":[107],"humidity":[109],"conditions.Average":[110],"found":[114,126,142],"be":[116,128,144,157,170],"21.40\u00b5m.Drug":[117],"content":[118],"determined":[121],"HPLC":[123],"98.6\u00b10.31%":[129],"while":[130],"efficiency":[132],"achieved":[133],"98.02%.Drug":[135],"from":[137],"the":[138],"final":[139],"formulation":[140],"90.3%":[145],"90":[147],"min.SLMs":[148],"formulated":[149],"with":[150,165],"taurocholate":[155],"can":[156],"delivery":[161],"hydrophobic":[163],"drugs":[164],"in-vivo":[166],"study":[167],"still":[168],"explored.":[171]},"counts_by_year":[{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}